Camber Pharmaceuticals, Inc. recalled Ketorolac Tromethamine Injection on October 1, 2025. The recall affects a specific lot due to the presence of glass particles. This recall pertains to the 60 mg/2 mL single-dose vials distributed nationwide.
Presence of Particulate Matter: Particulate matter identified as glass
Consumers and healthcare providers should stop using this product immediately. Contact Aspiro Pharma Limited or your healthcare provider for guidance. Notification method: Letter
The recalled product is Ketorolac Tromethamine Injection, USP, 60 mg/2 mL. Lot numbers include AS1240347A, AS1240144A, AS1240145A, AS1240146A, AS1250295A. The expiration dates range from May 2026 to May 2027.
The product poses a high risk due to the presence of particulate matter identified as glass. This contamination can lead to serious health risks if injected.
No specific incidents or injuries have been reported at this time. The severity of the hazard is classified as high.
Stop using the product immediately. Consumers should contact Aspiro Pharma Limited or their healthcare provider for further guidance.
For more information, call 1-866-495-1995 or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0036-2026.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.